Pearl, a global leader in dental AI, announced that it has raised $58 million in Series B funding to accelerate its mission to elevate patient care in dentistry. Left Lane Capital led the funding round, with participation from Smash Capital, Alpha Partners, and existing investors, Craft Ventures and Neotribe Ventures. This funding round marks the highest investment ever in dental artificial intelligence.
With this funding round, Pearl will continue to advance innovation in technologies that enhance the health of dental patients around the world by expanding its line of dental AI products, expanding its regulatory and patent portfolio, and increasing global access to the transformative benefits of AI in dentistry.
Pearl’s machine learning and computer vision tools solve a core challenge in dentistry: which is inconsistency in diagnostic accuracy and this directly impacts the quality of patient care. Plus, the company’s AI serves as a real-time aid to help dentists read patient x-rays, deliver consistent, objective, and accurate diagnoses, and clearly communicate findings to patients with precision, clarity, and confidence.
Since receiving the first-ever FDA clearance for AI software to help dental professionals detect multiple different pathologies and other conditions in x-rays, Pearl’s clinical AI gained regulatory authorizations for chairside use in over 120 countries. And the company plans to use the funding announced today to accelerate ongoing development of computer vision capabilities – including detection and tracking of disease in 3D and other imaging modalities – and introduce new AI tools to improve patient treatment planning, insurance claim approvals and dental education.
This funding follows a period of significant growth for Pearl. The company increased its revenue by 458% last year and remains the only dental AI company with a global market presence. And Pearl’s technology is used in dental practices across six continents and is commercially available to over 500,000 dental practices and millions of dental professionals worldwide. The company has also integrated its AI into dozens of popular imaging and practice management systems and is the preferred radiologic AI provider for leading dental technology distributors.
Pearl’s AI technology offers a seamless and less invasive approach to dental diagnostics. And by accurately detecting disease and displaying clinical findings that are easy for patients to understand, the company’s FDA-cleared software enhances the efficiency, consistency, and precision of radiologic exams, while also facilitating patient education and engagement in their dental health. Utilizing its new funding, Pearl will enable dental professionals to continually raising the standard of care with more transparent, accurate and objective diagnoses, more effective individualized care, and deeper patient trust in dentistry.
KEY QUOTES:
“In the field of healthcare, dentistry has become an AI standard-bearer, demonstrating the technology’s enormous utility and benefit in day-to-day patient care––and Pearl has led the AI charge in dentistry. This historic funding round underscores the impact of Pearl’s capabilities and supports our belief that high-quality, AI-powered dental care should be accessible to everyone. With this investment, Pearl will continue to push the envelope, providing pioneering machine learning to improve oral health outcomes and strengthen trust between the patient and dental professionals.”
– Ophir Tanz, founder and CEO of Pearl
“We have spent the past year evaluating this market and it is clear that Pearl stands above peers at the forefront of dental innovation. Pearl’s pioneering dental Al improves diagnostic accuracy and efficiency while transforming the provider-patient relationship. We’re confident in Pearl’s ability to continue setting new standards of care and are thrilled to support their next phase of growth.”
– Vinny Pujji, Managing Partner at Left Lane Capital
